Abstract
In this Practice Point commentary, we discuss the results and limitations of a nonrandomized, retrospective–prospective study of gonadotropin-releasing hormone analogs (GnRHa) in women with Hodgkin disease. Blumenfeld et al. concluded that coadministration of GnRHa during chemotherapy preserved cyclic ovarian function but not fertility. As the endocrine and ovulatory functions of the ovary are connected, this conclusion seems implausible. The study did not control for disease severity or the dose of alkylating agents. In addition, GnRHa treatment was not randomized, so patients in the control group were unlikely to have received GnRHa because the severity of their disease resulted in more-aggressive chemotherapy. By contrast, the only randomized study published to date showed no gonadal protection from GnRHa during chemotherapy in either sex. Furthermore, GnRHa did not prevent primordial-follicle loss in a human ovarian xenograft model. Unless a larger prospective study proves otherwise, GnRHa should not be offered as a proven method of fertility preservation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Blumenfeld Z et al. (2008) Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89: 166–173
Oktay K et al. (2007) Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 12: 1055–1066
Oktay K et al. (1997) Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab 82: 3748–3751
Familiari G et al. (1993) Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod 8: 2080–2087
Waxman JH et al. (1987) Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol 19: 159–162
Giuseppe L et al. (2007) Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology 12: 141–147
Maltaris T et al. (2007) The effect of a GnRH agonist on cryopreserved human ovarian grafts in severe combined immunodeficient mice. Reproduction 133: 503–509
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Oktay, K., Sönmezer, M. Gonadotropin-releasing hormone analogs in fertility preservation—lack of biological basis?. Nat Rev Endocrinol 4, 488–489 (2008). https://doi.org/10.1038/ncpendmet0892
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0892